AzTrials
AzTrials

Upper Cross SyndromeNCT06004076

Fascial Release on Upper Cross Syndrome.

A study testing Release of upper track of deep front fascial line and Corrective exercises for upper crossed syndrome in people with Upper Cross Syndrome, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will be a randomized controlled trial conducted to investigate the effect of release of upper track of deep front fascial line on patients with Upper Cross Syndrome.A sample size of 40 will be randomly allocated to two group ,(20 participants in each group), by using computer-generated random number list… Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Upper Cross Syndrome
What is being tested?
Release of upper track of deep front fascial line and Corrective exercises for upper crossed syndrome
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 10 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age ranged from 18 to 40 years.
  • Body Mass Index ≤30 kg/m².
  • All participants have forward head ,craniovertebral angle less than 48-50 degrees.
  • All participants have round back(kyphosis angle ≥ 42°).
  • The subjects were chosen from both genders.
  • Based on assessment for upper cross syndrome by photogrammetric analysis

Who cannot join

  • History of trauma or surgery in cervical region.
  • Bone fractures or acute soft tissue injuries .
  • Osteoporosis .
  • Heart attack .
  • Unstable angina pectoris .
  • Implanted pacemaker or defibrillator .
Show all 12Show fewer
  • Pregnant women.
  • Cancer .
  • Rheumatoid arthritis.
  • Connective tissue disease: This includes diseases such as osteomyelitis, lupus and scleroderma.
  • Neurological conditions.
  • -

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Physical Therapy Cairo University

    Giza

Other trials in Egypt

About this study

Official title: Effect of Release of Upper Track of Deep Front Fascial Line on Upper Cross Syndrome.

This study will be a randomized controlled trial conducted to investigate the effect of release of upper track of deep front fascial line on patients with Upper Cross Syndrome.A sample size of 40 will be randomly allocated to two group ,(20 participants in each group), by using computer-generated random number list method.

Experimental group will receive release of upper track of deep front fascial line in addition supervised corrective exercises for upper crossed syndrome and Control group which will receive supervised corrective exercise only. Both groups will receive eight sessions (2 sessions per week for 4 weeks).

Read the detailed description

Upper Cross Syndrome is a characterized by muscular imbalance of skeletal muscles activation and inhibition rather than just single muscle involvement. Individuals who present with upper crossed syndrome will show a forward head and neck posture Working in abnormal posture for prolonged duration is the main risk factor.

Although this posture does not necessarily lead to pain, but when prolonged, individuals do often experience upper back and neck pain.Stress on cervico-cranial and Cervico-thoracic junction is caused by the poor posture .Some postural patterning of forward shoulders, increases kyphosis, forward head posture, and loss of cervical lordosis is created by this poor posture.

Many researches studied effect of Exercises, stretching ,muscle energy technique,active release technique.Research on fascia gains more and more attention in basic science.

Fascial tissue plays an important role not only in functional anatomy,but also in sport and exercise science as well as in numerous therapeutic approaches as well as in clinical rehabilitation.Accordingly,There is no studies in the literature investigated the the effect of release of upper anterior track of deep front fascial line in subjects with upper cross syndrome, therefore this is the purpose study.

Being tested
Release of upper track of deep front fascial line, Corrective exercises for upper crossed syndrome
Medical subject headings
Oculocerebral hypopigmentation syndrome type Preus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Release of upper track of deep front fascial lineOther

    I will work on upper track of deep front fascial line, I will make release to diaphragm,mediastinum,scalene muscles, scalene fascia,Fascia endothoracic, transversus thoracis,Infrahyoid muscles, fascia pretracheal and Suprahyoid muscles.

  • Corrective exercises for upper crossed syndromeOther

    strength for scapular muscles and deep neck flexor

Study groups in NCT06004076
Study groupRoleWhat they receive
Release GroupExperimentalRelease of upper track of deep front fascial line
Receives: Other: Release of upper track of deep front fascial line; Other: Corrective exercises for upper crossed syndrome
Corrective GroupOtherCorrective exercises for upper crossed syndrome.
Receives: Other: Corrective exercises for upper crossed syndrome

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neck disability index

    The neck disability index (NDI) is the most widely used and validated instrument to assess the impact of neck pain on the patient's functional activities and to measure outcomes in clinical practice and research.

    Each of the 10 items scores from 0 to 5. The maximum score is 50. The obtained score can be multiplied by two to produce a percentage score.

    The disability categories for NDI are 0-8%, no disability; 10-28%, mild; 30-48%, moderate; 50-64%, severe; and 70-100%, complete dysfunction.

    Measured: up to 4 weeks

  2. Craniovertebral angle (CVA)

    The CVA is the angle between a horizontal line passing through the spinous process of C7, and a line extending from the tragus of the ear to C7.

    Photogrammetric analysis will be used to measure the angle.A lateral photograph of the craniocervical region were taken simultaneously from each subject's lateral side view,the distance between the camera and subject will be 150 cm, and the height of the camera will be held at the shoulder height of each subject and each subject will be told to stand in their bare feet.

    The subjects were instructed to fix their eyes on a marker that was attached to the front wall at height of eye while they were comfortably standing straight. were then instructed to assume their natural standing position on a paper sheet barefoot .

    Then, using the USC software application, the angle of the line connecting the tragus and the seventh neck vertebra with the perpendicular line is the forward head angle.

    Measured: up to 4 weeks

Secondary outcomes (2)
  1. Thoracic kyphosis angle

    To measure the angle of the kyphosis from the bone marker of the spinous process of the seventh vertebra will be used as the starting point of the arc and the spinous process of the 12th dorsal vertebra, T12, was used as the endpoint of the arch .Then, three photos are taken in three numbers using the camera. Then, the digital photos are transferred to the computer and are analyzed using the USC software application.

    Finally, the mean of three measurements is considered as the alignment angle.This method has a high correlation coefficient with the Cobb angle (0.83, 0.89) and precise.

    Measured: up to 4 weeks

  2. Chest expansion

    The tape-measure will be used for measuring thoracic expansion. Chest expansion, defined as the difference in thoracic girth after maximum inspiration and maximum expiration, is one indicator of chest wall mobility.

    The upper Chest expansion measurements is more useful in clinical practice to evaluate chest mobility and to give indirect information on lung volume function and inspiratory muscle strength.The anatomical marks for upper thoracic expansion are the third intercostal space, the middle of the clavicular line, and spinous process of the fifth thoracic vertebrae.

    The anatomical marks for lower thoracic expansion are the xiphoid process and spinous process of the 10th thoracic vertebrae.

    Measured: up to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2023
  2. Study start1 Aug 2023
  3. Primary completion4 Jan 2024
  4. Study completion10 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Release of upper track of deep front fascial line and supervised corrective exercises
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06004076
Sponsor's protocol ID
UCS
Status last verified
Aug 2024
First submitted
8 Aug 2023
Last updated
23 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Release of upper track of deep front fascial line and Corrective exercises for upper crossed syndrome in people with Upper Cross Syndrome, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neck disability index (time frame: up to 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in